Is Acetylsalicylic Acid Plus Dipyridamole Superior to ASA Alone for Secondary Prevention of Stroke?

Overview

Journal Can Fam Physician

Specialties General Medicine
Public Health

Date 2002 Jan 5

PMID 11768921

Authors

B Dalton

C Papoushek

M F Evans

Affiliations

Soon will be listed here.

References

Bousser M, Eschwege E, Haguenau M, Lefaucconnier J, Thibult N, Touboul D . "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke. 1983; 14(1):5-14. DOI: 10.1161/01.str.14.1.5. View

Farrell B, Godwin J, Richards S, Warlow C . The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991; 54(12):1044-54. PMC: 1014676. DOI: 10.1136/jnnp.54.12.1044. View

DYKEN M, Barnett H, Easton J, Fields W, Fuster V, Hachinski V . Low-dose aspirin and stroke. "It ain't necessarily so". Stroke. 1992; 23(10):1395-9. DOI: 10.1161/01.str.23.10.1395. View

Lutomski D, Bottorff M, Sangha K . Pharmacokinetic optimisation of the treatment of embolic disorders. Clin Pharmacokinet. 1995; 28(1):67-92. DOI: 10.2165/00003088-199528010-00006. View

Slattery J, Warlow C, Shorrock C, Langman M . Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial. Gut. 1995; 37(4):509-11. PMC: 1382902. DOI: 10.1136/gut.37.4.509. View

Hart R, Harrison M . Aspirin wars: the optimal dose of aspirin prevent stroke. Stroke. 1996; 27(4):585-7. DOI: 10.1161/01.str.27.4.585. View

Barnett H, Kaste M, Meldrum H, Eliasziw M . Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts. Stroke. 1996; 27(4):588-92. DOI: 10.1161/01.str.27.4.588. View

Patrono C, Roth G . Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen?. Stroke. 1996; 27(4):756-60. DOI: 10.1161/01.str.27.4.756. View

Hervey P, Goa K . Extended-release dipyridamole/aspirin. Drugs. 1999; 58(3):469-75; discussion 476-7. DOI: 10.2165/00003495-199958030-00007. View

10.

Albers G, Amarenco P, Easton J, Sacco R, Teal P . Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 2001; 119(1 Suppl):300S-320S. DOI: 10.1378/chest.119.1_suppl.300s. View

11.

Albers G, Hart R, Lutsep H, Newell D, Sacco R . AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: A statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Stroke. 1999; 30(11):2502-11. DOI: 10.1161/01.str.30.11.2502. View

12.

Lenz T, Hilleman D . Aggrenox: a fixed-dose combination of aspirin and dipyridamole. Ann Pharmacother. 2000; 34(11):1283-90. DOI: 10.1345/aph.10079. View

13.

FitzGerald G . Dipyridamole. N Engl J Med. 1987; 316(20):1247-57. DOI: 10.1056/NEJM198705143162005. View

14.

van Gijn J, Algra A, Kappelle J, Koudstaal P, van Latum A . A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med. 1991; 325(18):1261-6. DOI: 10.1056/NEJM199110313251801. View

15.

Hass W, Easton J, Adams Jr H, Pryse-Phillips W, Molony B, Anderson S . A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med. 1989; 321(8):501-7. DOI: 10.1056/NEJM198908243210804. View